InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,528.80
(
0.62%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.62
(
-0.09%
)
Bitcoin
65,645.88
(
1.04%
)
Post# of 258
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HopeUnderstand

Send PM Follow Ignore
Followers 0
Posts 257
Boards Moderated 0
Alias Born 04/18/2009

HopeUnderstand

Re: None

Friday, 08/28/2009 11:03:37 AM

Friday, August 28, 2009 11:03:37 AM

Post# of 258
According to the FDA briefing document, it looks like the FDA will want more trials...

Here's my question: If the advisory committee recommends it for approval, the FDA could possibly just grant conditional approval of Onrigin, right? That would mean they would have to conduct another trial after "approval", before they could market it.

JMO.

Let me know your thoughts...

All posts are in my opinion. Do not buy or sell based on my opinion.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up